Post-allogeneic hematopoietic stem cell transplantation viral reactivations and viremias: a focused review on human herpesvirus-6, BK virus and adenovirus.

Therapeutic Advances in Infectious Disease
Xin WangJan Cerny

Abstract

Human cytomegalovirus and Epstein-Barr virus have been recognized as potential drivers of morbidity and mortality of patients undergoing allogeneic stem cell transplantation for years. Specific protocols for monitoring, prophylaxis and pre-emptive therapy are in place in many transplant settings. In this review, we focus on the next three most frequent viruses, human herpesvirus-6, BK virus and adenovirus, causing reactivation and/or viremia after allogeneic transplant, which are increasingly detected in patients in the post-transplant period owing to emerging techniques of molecular biology, recipients' characteristics, treatment modalities used for conditioning and factors related donors or stem cell source. Given the less frequent detection of an illness related to these viruses, there are often no specific protocols in place for the management of affected patients. While some patients develop significant morbidity (generally older), others may not need therapy at all (generally younger or children). Furthermore, some of the antiviral therapies used are potentially toxic. With the addition of increased risk of secondary infections, risk of graft failure or increased risk of graft-versus-host disease as well as the relationsh...Continue Reading

References

Apr 1, 1977·American Journal of Epidemiology·J P FoxM K Cooney
Jan 1, 1992·The Journal of Infectious Diseases·M G MichaelsT E Starzl
Feb 28, 1985·The New England Journal of Medicine·A F ShieldsJ D Meyers
Jan 1, 1982·Journal of Medical Virology·J GoudsmitJ van der Noordaa
Apr 1, 1994·The Journal of Infectious Diseases·P FlomenbergN Bunin
Feb 14, 1998·The Journal of General Virology·M YasukawaS Fujita
Nov 25, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·F M MunozG J Demmler
Dec 16, 1998·Journal of Virology·M LuppiG Torelli
Apr 8, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P RibaudE Gluckman
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D S HowardC Pomeroy
Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B M Imbert-MarcilleN Milpied
Mar 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A M La RosaE Whimbey
Aug 11, 2001·Bone Marrow Transplantation·T YoshikawaY Nishiyama
Sep 1, 2001·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·J A HoffmanN Kapoor
Jan 5, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Danielle M ZerrLawrence Corey
Feb 19, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A C LankesterA C M Kroes
Aug 13, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marco W SchilhamMaarten J van Tol
Feb 1, 2003·The Lancet Infectious Diseases·Tony WallsDelane Shingadia
Apr 1, 2003·Bone Marrow Transplantation·P LjungmanUNKNOWN Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Jun 28, 2003·Blood·Alison SmithPaolo Lusso
Oct 11, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Sylvia StrackeFrieder Keller
Oct 11, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Osemwegie E EmovonSally Self
Dec 18, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marianne Leruez-VilleChristine Rouzioux
Jun 18, 2004·Emerging Infectious Diseases·Eric DenesSylvie Ranger-Rogez
Jul 10, 2004·The Journal of Infectious Diseases·Deborah J BidansetEarl R Kern
Oct 16, 2004·The Journal of General Virology·Elisabeth Andre-GarnierBerthe-Marie Imbert-Marcille
Dec 21, 2004·British Journal of Haematology·Marcus HentrichHans-Jochem Kolb
Jan 18, 2005·Clinical Microbiology Reviews·Leen De BolleErik De Clercq
Jan 19, 2005·The Journal of Infectious Diseases·Bianca HeemskerkMaarten J D van Tol
Feb 25, 2005·The New England Journal of Medicine·Danielle M ZerrLawrence Corey
Apr 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Danielle M ZerrMichael Boeckh
Aug 30, 2005·Antimicrobial Agents and Chemotherapy·Stephanie L Williams-AzizEarl R Kern
Nov 17, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·William J MullerRoger Giller

❮ Previous
Next ❯

Related Concepts

Related Feeds

BK Virus Infection

BK virus infection is a significant complication of modern immunosuppression used in kidney transplantation. Discover the latest research on BK virus infection here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.